Back to search

PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata

Data up to Jan 2025

Published2007
Citations407
References26

Total Citations Per Year

Abstract

References (26)

TNM Classification of Malignant Tumours

1987 • 16,209 citations

Regression Modeling Strategies

2001 • 8,706 citations

Regression Modeling Strategies

2015 • 5,442 citations

Two-sided confidence intervals for the single proportion: comparison of seven methods

1998 • 4,805 citations

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

2002 • 4,625 citations

TNM Classification of Malignant Tumours

2003 • 3,865 citations

Restoring function in exhausted CD8 T cells during chronic viral infection

2005 • 3,743 citations

Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

2001 • 3,343 citations

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

2002 • 2,879 citations

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

2006 • 2,702 citations

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

2006 • 2,521 citations

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1999 • 2,380 citations

Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity

2005 • 972 citations

Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

2006 • 826 citations

Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy

2003 • 758 citations

Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer

2005 • 758 citations

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

2004 • 742 citations

BCG immunotherapy of bladder cancer: 20 years on

1999 • 469 citations

Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade

2006 • 396 citations

618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target

2005 • 358 citations

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder

2005 • 211 citations

Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma.

2005 • 64 citations

Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture.

1976 • 28 citations

Immunological Profile of Patients with Transitional Cell Carcinoma of the Bladder

1982 • 21 citations

Commentary on the Immunobiology of Bladder Cancer

1977 • 20 citations

A Newly Illustrated Synopsis of the World Health Organization/ International Society of Urological Pathology (WHO/ISUP) Consensus Classification of Urothelial (Transitional-Cell) Neoplasms of the Urinary Bladder

1999 • 11 citations

Cited By (0)

No citing papers found in database

PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced… (2007) – Cancer | Metascience Observatory Explorer